MedPath

Effects of Plasmapheresis on Aging Biomarkers

Completed
Conditions
Aging
Plasmapheresis
Registration Number
NCT05004220
Lead Sponsor
Charles University, Czech Republic
Brief Summary

The aim of the study is to evaluate the effect of plasmapheresis (repeated plasma withdrawals) on selected health indicators (hematological, biochemical, immunological and indicators of biological age) of plasma donors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  1. Generally healthy volunteer subjects age 40 - 60
  2. 50:50 man and woman
Exclusion Criteria
  1. Subjects excluded from plasma donation protocols (serious illness, infection, etc)
  2. Subjects undergoing stronger anti-aging interventions

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant change of biological age according to epigenetic clock after 8 plasmapheresesThrough study completion, an average of 8 months

Significant change of the epigenetic age of the plasma donors after 8 cycles of plasmapheresis conducted or a slower increase of the biological age throughout the study than the increase of the chronological age.

Secondary Outcome Measures
NameTimeMethod
Significant change of the proteomic profile after 4 plasmapheresesThrough study completion, an average of 8 months

Proteomic analysis showing signs of a rejuvenated proteostasis in the plasma donors after 8 cycles of plasmapheresis.

Significant change of the biological age according to a blood biochemistry clock after 4 plasmapheresesThrough study completion, an average of 8 months

Blood biochemistry clock showing phenotype of a younger individual in the plasma donors after 8 cycles of plasmapheresis.

Significant change of biological age according to epigenetic clock after 8 plasmapheresesThrough study completion, an average of 8 months

Significant change of the epigenetic age of the plasma donors after 4 cycles of plasmapheresis conducted or a slower increase of the biological age throughout the study than the increase of the chronological age.

Significant change of the proteomic profile after 8 plasmapheresesThrough study completion, an average of 8 months

Proteomic analysis showing signs of a rejuvenated proteostasis in the plasma donors after 8 cycles of plasmapheresis.

Significant change of the biological age according to a blood biochemistry clock after 8 plasmapheresesThrough study completion, an average of 8 months

Blood biochemistry clock showing phenotype of a younger individual in the plasma donors after 8 cycles of plasmapheresis.

Trial Locations

Locations (1)

Charles University, Medical Faculty in Hradec Kralove

🇨🇿

Hradec Králové, Czechia

Charles University, Medical Faculty in Hradec Kralove
🇨🇿Hradec Králové, Czechia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.